- Home
- PRPL vs VTGN Comparison
PRPL vs VTGN Comparison
Compare PRPL & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- VTGN
- Stock Information
- Founded
- PRPL 2010
- VTGN 1998
- Country
- PRPL United States
- VTGN United States
- Employees
- PRPL N/A
- VTGN N/A
- Industry
- PRPL Home Furnishings
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- VTGN Health Care
- Exchange
- PRPL Nasdaq
- VTGN Nasdaq
- Market Cap
- PRPL 96.8M
- VTGN 70.0M
- IPO Year
- PRPL N/A
- VTGN N/A
- Fundamental
- Price
- PRPL $0.73
- VTGN $2.02
- Analyst Decision
- PRPL Hold
- VTGN
- Analyst Count
- PRPL 2
- VTGN 0
- Target Price
- PRPL $1.25
- VTGN N/A
- AVG Volume (30 Days)
- PRPL 666.3K
- VTGN 183.5K
- Earning Date
- PRPL 08-04-2025
- VTGN 06-17-2025
- Dividend Yield
- PRPL N/A
- VTGN N/A
- EPS Growth
- PRPL N/A
- VTGN N/A
- EPS
- PRPL N/A
- VTGN N/A
- Revenue
- PRPL $472,015,000.00
- VTGN $486,000.00
- Revenue This Year
- PRPL N/A
- VTGN N/A
- Revenue Next Year
- PRPL $10.65
- VTGN $943.32
- P/E Ratio
- PRPL N/A
- VTGN N/A
- Revenue Growth
- PRPL N/A
- VTGN N/A
- 52 Week Low
- PRPL $0.56
- VTGN $1.90
- 52 Week High
- PRPL $1.50
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- PRPL 48.69
- VTGN 36.36
- Support Level
- PRPL $0.70
- VTGN $1.94
- Resistance Level
- PRPL $0.82
- VTGN $2.18
- Average True Range (ATR)
- PRPL 0.05
- VTGN 0.16
- MACD
- PRPL -0.00
- VTGN -0.03
- Stochastic Oscillator
- PRPL 45.34
- VTGN 5.36
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.